The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: a mini review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of drug targeting (Print)

• Publication date

  2017-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/1061186X.2016.1223676PMID 27581650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of nicotinic acetylcholine receptor alpha 1 (nAChRα1) peptides on rabies virus infection in neuronal cells.

  2016cited by this paper
• A new strategy for specific imaging of neural cells based on peptide-conjugated gold nanoclusters

  2015cited by this paper
• Rabies Glycoprotein: A Benefit to the Virus, us or both?

  2015cited by this paper
• Role of cerebellar adrenomedullin in blood pressure regulation.

  2015cited by this paper
• Rabies Virus Envelope Glycoprotein Targets Lentiviral Vectors to the Axonal Retrograde Pathway in Motor Neurons*

  2014cited by this paper
• Bufotenine is able to block rabies virus infection in BHK-21 cells

  2014cited by this paper
• Schwann Cells Sense and Control Acetylcholine Spillover at the Neuromuscular Junction by α7 Nicotinic Receptors and Butyrylcholinesterase

  2014cited by this paper
• Cellular Uptake Mechanism and Therapeutic Utility of a Novel Peptide in Targeted-Delivery of Proteins into Neuronal Cells

  2013cited by this paper
• Targeted Delivery of Proteins into the Central Nervous System Mediated by Rabies Virus Glycoprotein-Derived Peptide

  2012cited by this paper
• RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain.

  2011cited by this paper
• α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease

  2011cited by this paper
• Differential use of the nicotinic receptor by rabies virus based upon substrate origin

  2011cited by this paper
• The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain

  2011cited by this paper
• Antibodies to cell surface proteins redirect intracellular trafficking pathways.

  2011cited by this paper
• Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles

  2011cited by this paper
• In vitro models of the blood-brain barrier.

  2011cited by this paper
• Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

  2010cited by this paper
• Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery.

  2010cited by this paper
• Neural cell adhesion molecule is required for stability of reinnervated neuromuscular junctions

  2010cited by this paper
• Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.

  2009cited by this paper
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• In silico models for the human alpha4beta2 nicotinic acetylcholine receptor.

  2008cited by this paper
• Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis.

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Rabies virus receptors

  2008influential reference
• Transvascular delivery of small interfering RNA to the central nervous system

  2007cited by this paper
• The Rabies Virus Glycoprotein Receptor p75NTR Is Not Essential for Rabies Virus Infection

  2007cited by this paper
• Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

  2006influential reference
• Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells.

  2006cited by this paper
• Journal of Neuroinflammation BioMed Central

  2005cited by this paper
• Rabies virus receptors

  2005cited by this paper
• Neural cell adhesion molecule function is regulated by metalloproteinase‐mediated ectodomain release

  2005cited by this paper
• Rabies virus interaction with various cell lines is independent of the acetylcholine receptor

  2005influential reference
• The blood-brain barrier: an overview: structure, regulation, and clinical implications.

  2004cited by this paper
• Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors.

  2004cited by this paper
• Neuronal nicotinic receptors: from structure to pathology.

  2004cited by this paper
• The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands

  2003cited by this paper
• The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands.

  2003cited by this paper
• Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells.

  2002cited by this paper
• Nicotinic receptor signaling in nonexcitable cells.

  2002cited by this paper
• Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus.

  2002cited by this paper
• Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors

  2001cited by this paper
• Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

  2001cited by this paper
• Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors.

  2001cited by this paper
• Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study.

  2000influential reference
• Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

  2000cited by this paper
• Translocational changes of localization of synapsin in axonal sprouts of regenerating rat sciatic nerves after ligation crush injury.

  2000cited by this paper
• Neuronal nicotinic receptors in the human brain.

  2000cited by this paper
• Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

  2000cited by this paper
• Rabies virus entry at the neuromuscular junction in nerve–muscle cocultures

  2000cited by this paper
• Nicotinic receptors in human brain: topography and pathology.

  2000cited by this paper
• Expression of functional α7 nicotinic acetylcholine receptor during mammalian muscle development and denervation

  1999cited by this paper
• Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus

  1998cited by this paper
• Neuronal Cell Surface Molecules Mediate Specific Binding to Rabies Virus Glycoprotein Expressed by a Recombinant Baculovirus on the Surfaces of Lepidopteran Cells

  1998cited by this paper
• Regulation of Nicotinic Receptor Subtypes Following Chronic Nicotinic Agonist Exposure in M10 and SH‐SY5Y Neuroblastoma Cells

  1998cited by this paper
• Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors.

  1998cited by this paper
• The Neural Cell Adhesion Molecule Is a Receptor for Rabies Virus

  1998cited by this paper
• Rabies virus infection of IMR-32 human neuroblastoma cells and effect of neurochemical and other agents.

  1997cited by this paper
• Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function.

  1997cited by this paper
• Partial inhibition of the in vitro infection of adult mouse dorsal root ganglion neurons by rabies virus using nicotinic antagonists.

  1997cited by this paper
• Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.

  1997cited by this paper
• Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay.

  1996cited by this paper
• Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation.

  1996cited by this paper
• Neuronal nicotinic receptors: molecular organization and regulations.

  1995cited by this paper
• Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization.

  1995cited by this paper
• Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor.

  1991cited by this paper
• Rabies virus binding to an acetylcholine receptor α‐subunit peptide

  1990cited by this paper
• Rabies virus binding to an acetylcholine receptor alpha-subunit peptide.

  1990influential reference
• Rabies virus infection of cultured rat sensory neurons

  1987cited by this paper
• Characterization of saturable binding sites for rabies virus

  1984cited by this paper
• Is the acetylcholine receptor a rabies virus receptor?

  1982cited by this paper
• Send Orders of Reprints at Reprints@benthamscience.net Nicotinic Receptors in Neurodegeneration

  year unknowncited by this paper

• Bioengineered extracellular vesicles mitigate neuroinflammation by neutralizing pneumolysin and delaying disease onset in experimental pneumococcal meningitis

  2026cites this paper
• Engineered reconstructed extracellular vesicles coloaded with Astragaloside IV/Paeoniflorin improve cerebral ischemia/reperfusion injurybyinhibiting the inflammatory response.

  2025cites this paper
• Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies

  2025cites this paper
• Development of a novel alpha7-nicotinic acetylcholine receptor-selective cell-penetrating peptide for intracellular cargo transport

  2025cites this paper
• Duplication of the Rabies Virus Glycoprotein Enhances the Virus Propagation Rate and Immunogenicity

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• Customised extracellular vesicle therapeutics for neurological conditions

  2025cites this paper
• Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations.

  2025cites this paper
• Role of Liposomes in the Treatment of Neurodegenerative Disorders: A Comprehensive Review.

  2025cites this paper
• Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments

  2025cites this paper
• 3D-Printed Oral Disintegrating Films of Brain-Targeted Acetyl Salicylic Acid Nanoparticles for Enhanced CNS Delivery in Ischemic Stroke

  2025cites this paper
• Development of a novel alpha7-nicotinic acetylcholine receptor-selective cell-penetrating peptide for intracellular cargo transport

  2025cites this paper
• Targeted Polymersomes Enable Enhanced Delivery to Peripheral Nerves Post-Injury

  2024cites this paper
• Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

  2024cites this paper
• Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease

  2024cites this paper
• Tumor-specific cytolysis by peptide-conjugated echogenic polymer micelles.

  2024cites this paper
• Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways

  2024cites this paper
• PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy

  2024cites this paper
• Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin

  2023cites this paper
• Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood-brain barrier for targeted drug delivery.

  2023cites this paper
• Poly (β-amino Ester) Nanoparticles Modified with a Rabies Virus-derived peptide for the Delivery of ASCL1 Across a 3D In Vitro Model of the Blood Brain Barrier.

  2023cites this paper
• Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis

  2022cites this paper
• Interactions between the rabies virus and nicotinic acetylcholine receptors: A potential role in rabies virus induced behavior modifications

  2022cites this paper
• Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery

  2022cites this paper
• The brain targeted delivery of programmed cell death 4 specific siRNA protects mice from CRS-induced depressive behavior

  2021cites this paper
• Viruses as Therapeutics: Methods and Protocols

  2021cites this paper
• Metabolomics Analysis of Viral Therapeutics.

  2021cites this paper
• Evolving new-age strategies to transport therapeutics across the blood-brain-barrier.

  2021cites this paper
• An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma.

  2021cites this paper
• Aptamer and RVG functionalized gold nanorods for targeted photothermal therapy of neurotropic virus infection in the mouse brain

  2021cites this paper
• Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

  2021cites this paper
• Extracellular vesicles as a drug delivery system:A systematic review of preclinical studies.

  2021cites this paper
• First evidence that emerging pinnatoxin-G, a contaminant of shellfish, reaches the brain and crosses the placental barrier.

  2021cites this paper
• Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

  2021cites this paper
• GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain

  2021cites this paper
• Emerging landscape of cell-penetrating peptide-mediated nucleic acid delivery and their utility in imaging, gene-editing, and RNA-sequencing.

  2021cites this paper
• Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight

  2021cites this paper
• Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.

  2021cites this paper
• Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene

  2021cites this paper
• Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles

  2020cites this paper
• Development Of A Liposomal Formulation For Brain Targeting

  2020cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.

  2020cites this paper
• Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach

  2020cites this paper
• An overview of nanomedicines for neuron targeting.

  2020cites this paper
• Lipid nanoparticles for nucleic acid delivery: Current perspectives.

  2020cites this paper
• A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes

  2020cites this paper
• RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery

  2020cites this paper
• Paclitaxel-loaded dextran nanoparticles decorated with RVG29 peptide for targeted chemotherapy of glioma: anin vivostudy

  2020cites this paper
• Efficient neuronal targeting and transfection using RVG and Transferrin-conjugated liposomes.

  2020cites this paper
• Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors

  2019cites this paper
• Targeted theranostic of cryptococcal encephalitis by a novel polypyridyl ruthenium complex.

  2019cites this paper
• Extracellular vesicles in the diagnosis and treatment of central nervous system diseases

  2019cites this paper
• Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System

  2019cites this paper
• Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis

  2019cites this paper
• Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide.

  2019cites this paper
• Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes

  2018cites this paper
• Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

  2018cites this paper
• Recent progress of drug nanoformulations targeting to brain

  2018cites this paper
• Targeted transport of nanocarriers into brain for theranosis with rabies virus glycoprotein-derived peptide.

  2017cites this paper